Valerie Yii, Anthony Moussa, Daranporn Triwongwaranat, Blake R C Smith, Bevin Bhoyrul
{"title":"原发性瘢痕性秃发移植后毛囊单位移植存活率的系统综述。","authors":"Valerie Yii, Anthony Moussa, Daranporn Triwongwaranat, Blake R C Smith, Bevin Bhoyrul","doi":"10.1097/DSS.0000000000004707","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Primary cicatricial alopecia (PCA) refers to a clinically diverse group of inflammatory hair loss disorders characterized by the irreversible destruction and scarring of hair follicles. Hair transplantation (follicular unit extraction [FUE] or strip harvesting follicular unit transplantation [FUT]) has been proposed as a treatment for inactive PCA.</p><p><strong>Objective: </strong>This study aims to evaluate the efficacy and safety of HT for the management of PCA.</p><p><strong>Methods: </strong>A systematic review was conducted to identify studies assessing treatment of PCA in adults (≥18 years) with FUE or FUT. The primary outcome measure was follicular unit (FU) graft survival rate. Secondary outcomes included postoperative complications and patient satisfaction.</p><p><strong>Results: </strong>Eight observational studies with a total of 123 patients met the inclusion criteria. Overall, the weighted FU graft survival rate after HT was 82.7% at 7 to 12 months, 73.3% at 13 to 24 months, 58.4% at 25 to 36 months, 55.4% at 37 to 48 months and 39.6% at 49 to 72 months. Four patients developed reactivation of their disease after HT.</p><p><strong>Conclusion: </strong>The FU graft survival rate after FUE or FUT for the management of inactive PCA peaks at 1 year and diminishes over time.</p>","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Systematic Review of Follicular Unit Graft Survival Rates After Hair Transplantation in Primary Cicatricial Alopecia.\",\"authors\":\"Valerie Yii, Anthony Moussa, Daranporn Triwongwaranat, Blake R C Smith, Bevin Bhoyrul\",\"doi\":\"10.1097/DSS.0000000000004707\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Primary cicatricial alopecia (PCA) refers to a clinically diverse group of inflammatory hair loss disorders characterized by the irreversible destruction and scarring of hair follicles. Hair transplantation (follicular unit extraction [FUE] or strip harvesting follicular unit transplantation [FUT]) has been proposed as a treatment for inactive PCA.</p><p><strong>Objective: </strong>This study aims to evaluate the efficacy and safety of HT for the management of PCA.</p><p><strong>Methods: </strong>A systematic review was conducted to identify studies assessing treatment of PCA in adults (≥18 years) with FUE or FUT. The primary outcome measure was follicular unit (FU) graft survival rate. Secondary outcomes included postoperative complications and patient satisfaction.</p><p><strong>Results: </strong>Eight observational studies with a total of 123 patients met the inclusion criteria. Overall, the weighted FU graft survival rate after HT was 82.7% at 7 to 12 months, 73.3% at 13 to 24 months, 58.4% at 25 to 36 months, 55.4% at 37 to 48 months and 39.6% at 49 to 72 months. Four patients developed reactivation of their disease after HT.</p><p><strong>Conclusion: </strong>The FU graft survival rate after FUE or FUT for the management of inactive PCA peaks at 1 year and diminishes over time.</p>\",\"PeriodicalId\":11289,\"journal\":{\"name\":\"Dermatologic Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dermatologic Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/DSS.0000000000004707\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatologic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/DSS.0000000000004707","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
A Systematic Review of Follicular Unit Graft Survival Rates After Hair Transplantation in Primary Cicatricial Alopecia.
Background: Primary cicatricial alopecia (PCA) refers to a clinically diverse group of inflammatory hair loss disorders characterized by the irreversible destruction and scarring of hair follicles. Hair transplantation (follicular unit extraction [FUE] or strip harvesting follicular unit transplantation [FUT]) has been proposed as a treatment for inactive PCA.
Objective: This study aims to evaluate the efficacy and safety of HT for the management of PCA.
Methods: A systematic review was conducted to identify studies assessing treatment of PCA in adults (≥18 years) with FUE or FUT. The primary outcome measure was follicular unit (FU) graft survival rate. Secondary outcomes included postoperative complications and patient satisfaction.
Results: Eight observational studies with a total of 123 patients met the inclusion criteria. Overall, the weighted FU graft survival rate after HT was 82.7% at 7 to 12 months, 73.3% at 13 to 24 months, 58.4% at 25 to 36 months, 55.4% at 37 to 48 months and 39.6% at 49 to 72 months. Four patients developed reactivation of their disease after HT.
Conclusion: The FU graft survival rate after FUE or FUT for the management of inactive PCA peaks at 1 year and diminishes over time.
期刊介绍:
Exclusively devoted to dermatologic surgery, the Dermatologic Surgery journal publishes the most clinically comprehensive and up-to-date information in its field. This unique monthly journal provides today’s most expansive and in-depth coverage of cosmetic and reconstructive skin surgery and skin cancer through peer-reviewed original articles, extensive illustrations, case reports, ongoing features, literature reviews and correspondence. The journal provides information on the latest scientific information for all types of dermatologic surgery including:
-Ambulatory phlebectomy-
Blepharoplasty-
Body contouring-
Chemical peels-
Cryosurgery-
Curettage and desiccation-
Dermabrasion-
Excision and closure-
Flap Surgery-
Grafting-
Hair restoration surgery-
Injectable neuromodulators-
Laser surgery-
Liposuction-
Microdermabrasion-
Microlipoinjection-
Micropigmentation-
Mohs micrographic surgery-
Nail surgery-
Phlebology-
Sclerotherapy-
Skin cancer surgery-
Skin resurfacing-
Soft-tissue fillers.
Dermatologists, dermatologic surgeons, plastic surgeons, oculoplastic surgeons and facial plastic surgeons consider this a must-read publication for anyone in the field.